<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01897662</url>
  </required_header>
  <id_info>
    <org_study_id>ROQ_NUTRIMETAB10</org_study_id>
    <secondary_id>2011-A00062-39</secondary_id>
    <nct_id>NCT01897662</nct_id>
  </id_info>
  <brief_title>Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects</brief_title>
  <acronym>ROQ_NUTRIMETAB</acronym>
  <official_title>Study of the Consumption of Nutriose on Satiety, Weight Loss and Fat Mass Reducing in Overweight Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nealth Sarl</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roquette Freres</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nealth Sarl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NUTRIOSE is a food ingredient defined as a carbohydrate polymer of vegetable origin (wheat
      starch or corn) with a degree of polymerization ≥ 3 and chemically transformed. It is soluble
      in aqueous solution, very poorly digested in the small intestine, it mostly reaches the colon
      where it stimulates fermentation. AFSSA, in its opinion of July 30, 2007, considers that this
      ingredient is a &quot;soluble dietary fiber.&quot; Recent work in China in overweight volunteers have
      shown an effect of NUTRIOSE on satiation and satiety, and demonstrate an effect on reducing
      weight and fat mass. By its action on satiety and reduced food intake, the NUTRIOSE be of
      interest in the management of overweight or obese. Among the possible mechanisms of action,
      are the metabolites produced by colonic fermentation of NUTRIOSE.

      The goal of this biomedical research is to study the effect of a dose of 14g/day of NUTRIOSE
      FB06 for 12 weeks on the evolution of weight, percentage of body fat and digestive tolerance
      in Caucasians overweight subjects. To gather evidence to support mechanisms of action, it is
      proposed to measure before consumption, then every 4 weeks, the effects of NUTRIOSE FB06 on
      satiety and satiation and changes in colonic flora and its metabolites.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body weight</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>satiety</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>energy intake</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
    <description>Body Mass Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body fat</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
    <description>measured by DEXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>waist size</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glycemia</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insulinemia</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total cholesterol</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>triglyceridemia</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
    <description>homeostasis model assessment (appreciates peripheral insulinoresistance and deficit in insulin secretion)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>microbiota</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
    <description>measured by RT-PCR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>digestive tolerance</measure>
    <time_frame>D-7; D28; D56; D84</time_frame>
    <description>measured with daily questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>NUTRIOSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group of volunteers fed with NUTRIOSE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GLUCIDEX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group of volunteers fed with GLUCIDEX</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NUTRIOSE FB06</intervention_name>
    <description>14g/day NUTRIOSE FB06: 7g in 250 mL orange juice twice a day</description>
    <arm_group_label>NUTRIOSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>GLUCIIDEX 21</intervention_name>
    <description>7g/day GLUCIDEX 21 : 3.5g in 250 mL orange juice twice a day</description>
    <arm_group_label>GLUCIDEX</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy people

          -  aged between 20 and 50 years

          -  BMI between 27 and 29 kg/m2

          -  without metabolic syndrome

          -  no pregnant nor nursing women

          -  covered by Social Security

          -  negative serology for hepatitis B/C and HIV

          -  who signed the informed consent form

        Exclusion Criteria:

          -  persons abusing drugs (laxatives, anti-diarrheal, agents acting on satiety)

          -  person who doesn't want to stop taking food supplements containing pre- or probiotics
             during time of the study

          -  person intolerant to gluten and / or allergic to wheat flour

          -  person in diet during the last 3 months

          -  person in vegetarian or vegan diet

          -  person who donated blood during the 3 months preceding the study

          -  Inclusion in another clinical study

          -  subjects receiving over 4,500 Euros in the last 12 months (including the present
             study)

          -  subjects presenting risk of non-compliance in the opinion of the recruiting doctor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul VALENSI, PU/PH, Chef de service</last_name>
    <role>Principal Investigator</role>
    <affiliation>centre de recherche en nutrition humaine (CRNH)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CRNH, service de diabétologie-endocrinologie-nutrition hôpital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <state>Seine-Saint-Denis</state>
        <zip>93143</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Li S, Guerin-Deremaux L, Pochat M, Wils D, Reifer C, Miller LE. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab. 2010 Dec;35(6):773-82. doi: 10.1139/H10-074.</citation>
    <PMID>21164548</PMID>
  </reference>
  <reference>
    <citation>Slavin JL, Savarino V, Paredes-Diaz A, Fotopoulos G. A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res. 2009 Jan-Feb;37(1):1-17. Review.</citation>
    <PMID>19215668</PMID>
  </reference>
  <reference>
    <citation>Guerin-Deremaux L, Li S, Pochat M, Wils D, Mubasher M, Reifer C, Miller LE. Effects of NUTRIOSE® dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int J Food Sci Nutr. 2011 Sep;62(6):628-35. doi: 10.3109/09637486.2011.569492. Epub 2011 May 19.</citation>
    <PMID>21591985</PMID>
  </reference>
  <reference>
    <citation>Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005 May;71(5):2318-24.</citation>
    <PMID>15870317</PMID>
  </reference>
  <reference>
    <citation>Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J. 2010;57(5):359-72. Epub 2010 Apr 14. Review.</citation>
    <PMID>20424341</PMID>
  </reference>
  <reference>
    <citation>Ruskoné-Fourmestraux A, Attar A, Chassard D, Coffin B, Bornet F, Bouhnik Y. A digestive tolerance study of maltitol after occasional and regular consumption in healthy humans. Eur J Clin Nutr. 2003 Jan;57(1):26-30.</citation>
    <PMID>12548293</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2013</study_first_submitted>
  <study_first_submitted_qc>July 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2013</study_first_posted>
  <last_update_submitted>July 11, 2013</last_update_submitted>
  <last_update_submitted_qc>July 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>overweight</keyword>
  <keyword>satiety</keyword>
  <keyword>functional food</keyword>
  <keyword>food intake</keyword>
  <keyword>digestive tolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

